Chemed financials
$512.05−0.44%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $673.3M | $657.5M | $639.3M | $624.9M | $618.8M | $646.9M | $640.0M | $606.2M | $595.9M | $589.2M | $585.9M | $564.5M |
| Gross profit | $221.5M | $215.8M | $225.2M | $196.9M | $184.7M | $216.4M | $234.1M | $210.0M | $206.1M | $589.2M | $227.6M | $202.2M |
| Gross margin | 32.9% | 32.8% | 35.2% | 31.5% | 29.8% | 33.5% | 36.6% | 34.6% | 34.6% | 100.0% | 38.8% | 35.8% |
| Operating income | $89.2M | $84.6M | $100.7M | $74.8M | $68.1M | $94.8M | $113.9M | $92.2M | $88.1M | $72.3M | $111.4M | $86.8M |
| Net income | $67.7M | $66.3M | $76.8M | $64.2M | $52.5M | $71.8M | $90.3M | $75.8M | $70.9M | $65.0M | $90.1M | $75.0M |
| Net margin | 10.1% | 10.1% | 12.0% | 10.3% | 8.5% | 11.1% | 14.1% | 12.5% | 11.9% | 11.0% | 15.4% | 13.3% |
| Diluted EPS | $5.13 | $4.84 | $5.50 | $4.46 | $3.57 | $4.86 | $6.03 | $5.00 | $4.65 | $4.24 | $5.90 | $4.93 |
| EBITDA | $106.2M | $101.5M | $117.0M | $91.0M | $84.3M | $110.8M | $129.7M | $107.9M | $103.8M | $88.1M | $111.4M | $102.2M |
| Operating cash flow | $84.8M | $88.2M | $133.5M | $83.4M | $138.6M | $32.7M | $164.9M | $90.5M | $77.5M | $84.5M | $108.6M | $28.9M |
| Free cash flow | $69.3M | $71.1M | $117.2M | $66.0M | $122.8M | $19.5M | $152.2M | $77.0M | $66.5M | $72.4M | $96.8M | $17.3M |
| Diluted shares | 13.2M | 13.7M | 14.0M | 14.4M | 14.7M | 14.8M | 15.0M | 15.2M | 15.3M | 15.3M | 15.3M | 15.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $40.2M | $16.9M | $74.5M | $129.8M | $249.9M | $173.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $140.0M | $91.2M | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.58B | $1.54B | $1.54B | $1.62B | $1.72B | $1.73B |
| Total liabilities | $749.1M | $687.8M | $558.8M | $546.9M | $519.4M | $544.8M |
| Shareholders' equity | $830.5M | $848.0M | $979.4M | $1.08B | $1.20B | $1.18B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology